Population pharmacokinetics of emtricitabine in human immunodeficiency virus type 1-infected pregnant women and their neonates
about
Pre-exposure Prophylaxis Use by Breastfeeding HIV-Uninfected Women: A Prospective Short-Term Study of Antiretroviral Excretion in Breast Milk and Infant AbsorptionPopulation pharmacokinetics of emtricitabine in HIV-1-infected adult patientsProtecting the fetus against HIV infection: a systematic review of placental transfer of antiretrovirals.Population pharmacokinetics of nevirapine in HIV-1-infected pregnant women and their neonates.Modified renal function in pregnancy: impact on emtricitabine pharmacokinetics.Concentrations of tenofovir and emtricitabine in breast milk of HIV-1-infected women in Abidjan, Cote d'Ivoire, in the ANRS 12109 TEmAA Study, Step 2Very high concentrations of active intracellular phosphorylated emtricitabine in neonates (ANRS 12109 trial, step 2).Pharmacokinetics and safety of single-dose tenofovir disoproxil fumarate and emtricitabine in HIV-1-infected pregnant women and their infantsEffect of pregnancy on emtricitabine pharmacokinetics.Physiologically-based pharmacokinetic modeling of renally excreted antiretroviral drugs in pregnant women.Pharmacokinetic studies in infants using minimal-risk study designsPrediction of human fetal pharmacokinetics using ex vivo human placenta perfusion studies and physiologically based models.Pharmacotherapy in pregnancy; effect of ABC and SLC transporters on drug transport across the placenta and fetal drug exposure.Population pharmacokinetic analysis during the first 2 years of life: an overview.British HIV Association guidelines for the management of HIV infection in pregnant women 2012 (2014 interim review).Toward a universal antiretroviral regimen: special considerations of pregnancy and breast feeding.NRTI backbone in HIV treatment: will it remain relevant?A Physiologically-Based Pharmacokinetic Model to Predict Human Fetal Exposure for a Drug Metabolized by Several CYP450 Pathways.HIV Reverse Transcriptase InhibitorsTenofovir and tenofovir-diphosphate concentrations during pregnancy among HIV-uninfected women using oral preexposure prophylaxisBritish HIV Association guidelines for the management of HIV infection in pregnant women 2012
P2860
Q28554369-ED051042-4742-486B-A727-6D21D38E4BF2Q33622825-A7D295DD-87CB-444E-B9C3-830B21225F03Q34429204-9B669B17-AAB9-4E7A-A1A3-5303E6528675Q34483505-5211A3AE-1017-4F3C-BFF7-A9BEEF05898CQ34635554-5428D4F6-D1B8-4F0B-85CA-1DA0C39B5753Q34737231-3B25B569-EA9A-4E5B-AA50-CC7D371D13B6Q35004837-EEC09943-1C08-4993-B3AC-3C26FF641C35Q35598502-6EF78C9A-E906-48BE-9287-7D6E4C0894ECQ35930696-C77E8DAA-5F74-4F99-BD29-571BE97350D0Q36243626-FA9A071A-A093-49AC-8477-137B02C341B7Q36438116-0276EFCB-A41D-42DD-B905-7C1900CED2C1Q36706781-BB35E93A-A29B-466B-AEBD-25D3CDD13685Q38044958-FA8DF6A6-40B3-4679-8A41-EA8B7770978EQ38062388-D1D49AAB-23A9-4F8E-8856-A3B058C63464Q38325427-A5A4D27D-C374-47B3-827F-5CA9EE589A88Q38828635-54592074-DC0B-47EB-884A-715C2F308B0EQ39533858-CCF5BB68-46C2-4C4A-9F7F-B451C002258AQ48072950-7C6E911C-B214-449A-B4E3-E5A5C61841BDQ56786269-94473DB4-507D-443F-BD1F-C3499B9FDE79Q56910156-6D00822A-1DD7-4CED-AC92-7172362FC02CQ57076282-EC48621A-8AD9-4B96-A53D-FD3854954F7F
P2860
Population pharmacokinetics of emtricitabine in human immunodeficiency virus type 1-infected pregnant women and their neonates
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Population pharmacokinetics of ...... gnant women and their neonates
@en
Population pharmacokinetics of ...... nant women and their neonates.
@nl
type
label
Population pharmacokinetics of ...... gnant women and their neonates
@en
Population pharmacokinetics of ...... nant women and their neonates.
@nl
prefLabel
Population pharmacokinetics of ...... gnant women and their neonates
@en
Population pharmacokinetics of ...... nant women and their neonates.
@nl
P2093
P2860
P50
P356
P1476
Population pharmacokinetics of ...... gnant women and their neonates
@en
P2093
Didier K Ekouévi
Divine Avit
Déborah Hirt
Elisabeth Rey
Elise Arrivé
James McIntyre
Jean-Marc Tréluyer
Patrick Coffié
Saik Urien
Sarita Lalsab
P2860
P304
P356
10.1128/AAC.00860-08
P407
P577
2008-12-22T00:00:00Z